Inventor · disambiguated record
William C. Hahn
Also filed as: HAHN WILLIAM · HAHN WILLIAM C
9 granted patents·6 pending applications·12 citations·filing 1999–2024
81Inventor score
Files withDANA FARBER CANCER INST INC7BROAD INST INC3HAHN WILLIAM C3JAPAN HEALTH SCIENCE FOUND1ROBERTS THOMAS M1
Top patents by PatentIndex Score
15 records- 0183US12282014B2Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancersDANA FARBER CANCER INST INC·Filed 2016·Granted Apr 22, 2025·3 cites·6 claims
- 0281US8178317B2Compositions and methods for identifying transforming and tumor suppressor genesROBERTS THOMAS M·Filed 2008·Granted May 15, 2012·4 cites·35 claims
- 0378US2024398804A1Methods of treating cancer having an active wnt/beta-catenin pathwayDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 0466US12109212B2Methods of treating cancer having an active Wnt/β-catenin pathwayDANA FARBER CANCER INST INC·Filed 2019·Granted Oct 8, 2024·0 cites·14 claims
- 0565US8637260B2Phosphorylated RaIAHAHN WILLIAM C·Filed 2011·Granted Jan 28, 2014·1 cites·6 claims
- 0664US10426774B2Methods of treating cancer having an active Wnt/β-catenin pathwayDANA FARBER CANCER INST INC·Filed 2013·Granted Oct 1, 2019·1 cites·11 claims
- 0746US12152008B2Cyclopentaimidazolones for the treatment of cancerBROAD INST INC·Filed 2020·Granted Nov 26, 2024·0 cites·17 claims
- 0846US2022396777A1Patient-matched organoid systems for studying cancerDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0943US2011243910A1mammalian rna dependent rna polymeraseJAPAN HEALTH SCIENCE FOUND·Filed 2009·Application pending·0 cites
- 1042US9593377B2Signatures and determinants associated with cancer and methods of use thereofHAHN WILLIAM C·Filed 2011·Granted Mar 14, 2017·0 cites·5 claims
- 1142US2011206689A1Molecular Determinants Associated With Prostate Cancer And Methods Of Use ThereofDANA FARBER CANCER INST INC·Filed 2011·Application pending·0 cites
- 1242US2022090083A1Targeting egln1 in cancerBROAD INST INC·Filed 2019·Application pending·0 cites
- 1336US7851591B1Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERTDANA FARBER CANCER INST INC·Filed 1999·Granted Dec 14, 2010·3 cites·1 claims
- 1435US11492670B2Compositions and methods for targeting cancer-specific sequence variationsBROAD INST INC·Filed 2016·Granted Nov 8, 2022·0 cites·12 claims
- 1527US2009047672A1Telomerase RNA Subunit and Methods of Use ThereofHAHN WILLIAM C·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →